Drug intelligence / Profile preview

amitriptyline + propranolol

Development stage
Unknown
Lead developer
Centaur Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

**Amitriptyline + propranolol** is an oral fixed-dose combination of two small molecules used principally for migraine prophylaxis. Amitriptyline is a tricyclic antidepressant that inhibits neuronal norepinephrine and serotonin reuptake, while propranolol is a nonselective beta-adrenergic receptor blocker. The complementary pharmacology is intended to reduce migraine frequency and may be useful where migraine coexists with tension-type headache features. Marketed Indian products include extended-release tablet presentations such as Health N U's AmNuriteBeta. ([1mg.com](https://www.1mg.com/generics/amitriptyline-propranolol-405636))

Brand names
AM-BETAAmnotript-PRAmNuriteBetaEtosis PGaltrip BetaPro ATTriptamin PRTripbetaTriptololTryptojam-Pro
Other names
amitriptyline + propranololamitriptyline/propranolol
02

Targets

ADRA1A (α1A)ADRB1 (β1)ADRB2 (β2)HRH1 (Histamine H1 Receptor)mAChR (Muscarinic acetylcholine receptors)NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on amitriptyline + propranolol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amitriptyline + propranolol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call